- Pressure BioSciences to acquire the assets of a global, eco-friendly agrochemical supplier for worldwide distribution into food production markets
- Assets include formulations, manufacturer relationships, trademarks and other IP, registrations, licenses, and access to distributors and end-users
- Assets are being acquired from a company that was selling improved, effective, organically-natural, “green” agrochemical products
- Company expects that this new agrochemical business will not just be operational in 2021, but will generate significant revenue by the end of this year
- Worldwide market for agrochemicals is soaring
- PBI’S Patented Ultra Shear Technology(TM) (“UST”) produces high-quality stable nanoemulsions that can make oil-based products, such as perticides and fertilizers, far more water soluble and effective
South Easton, MA, February , 2021 – Pressure BioSciences (OTCQB: PBIO) (“PBI” or the “Company”), a global leader in the development and sale of broadly enabling, pressure-based instruments to the life sciences and other fields, announced it has signed a letter of intent to purchase the assets of an internationally-based, eco-friendly agrochemical developer. This developer was previously engaged in providing environmentally sustainable alternatives to synthetic pesticides and fertilizers for agricultural production worldwide.
Mr. Richard T. Schumacher, President, and CEO of PBI said “Upon completion, this acquisition of assets will bring into PBI an established portfolio of respected brand names in the eco-friendly agrochemicals market, with unique proprietary formulations, advantageous manufacturer relationships, trademarks, intellectual property, registrations and licenses, and access to the distributor and end-customer relationships around the world. We expect these assets to be accretive, driving significant new revenues and profitability in 2021 and beyond” (https://ibn.fm/Nxoj2).
As the demand for food production increases worldwide, environmental sustainability becomes a huge concern. This has paved the way for a new generation of environmental-friendly agrochemicals. Consequently, the worldwide market for Pesticides should reach $131B by 2023 (https://ibn.fm/GfkTf) and Fertilizers should reach $232B by 2025 (https://ibn.fm/GHX2J). The common challenge faced by Agrochemicals involves effective and increased absorption of oily (hydrophobic) active ingredients, required for increased availability within targeted plant species.
Pressure BioSciences was recently awarded its first U.S. patent for its novel Ultra Shear Technology (“UST”) platform, a process that has the potential of increasing the long-term stability, safety, water-solubility, and bio-availabity of many products in the pharmaceutical, nutraceutical, cosmetics, food and beverage, and now agricultural markets. UST is a nano emulsification platform, which can make oils effectively soluble in water. This technique is expected to provide improved agrochemical dosing while reducing the quantities of expensive active ingredients required (saving the manufacturer significant money).
The company has filed patents in U.S., Canada, Europe, and Asia. UST uniquely combines intense shear forces generated from ultra-high-pressure valve discharge, under controlled temperatures, to produce high-quality stable nanoemulsions. In addition to saving the manufacturer significant money during processing, UST can also significantly reduce foodborne pathogens, thus making the nanoemulsified product much safer.
As mentioned, the UST technology platform has the potential to play a pivotal role in a number of commercial sectors, e.g.,nutraceuticals, cosmetics, pharmaceuticals, cannabis oil extracts, industrial lubricants, and now agriculture where macro and micro emulsions of oil and water are commonly used.. Scientific studies indicate that nanoemulsions offer improved absorption, higher bioavailability, greater stability, lower surfactant levels, and other advantages over larger emulsions (https://ibn.fm/zFDA6).
About Pressure BioSciences Inc.
Pressure BioSciences is a global leader in the development and sale of innovative, pressure-based solutions for the life sciences market and other industries. The company’s products are based on the unique alternating pressure cycling technology (“PCT”). The company’s primary focus is on the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterror applications.
For more information, visit the company’s website at www.PressureBioSciences.com.
NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.